Sunday, May 19, 2024
Clinical Advances in
Read Overview
Supported by an independent educational grant from Janssen Pharmaceuticals, Inc
Developed through a partnership between Medscape and Society for Vascular Medicine (SVM).
Steering Committee Chair
Heart & Vascular Center Professor of Medicine
Harvard Medical School
Executive Director of Interventional Cardiovascular Programs
Brigham and Women’s Hospital
Boston, Massachusetts
Professor of Medicine
Director of Vascular Research
University of Colorado School of Medicine
Aurora, Colorado
Associate Professor of Medicine Warren Alpert
Medical School of Brown
University Medical Director
Heart & Vascular Service Line
Henry Ford Health
Detroit, Michigan
Assistant Professor of Medicine
Icahn School of Medicine at Mount Sinai
New York, New York
Cardiologist and Vascular Medicine
Atrium Health Sanger Heart and Vascular Institute
Charlotte, North Carolina
Clinical Assistant Professor
Case Western Reserve University School of Medicine
University Hospitals
Cleveland, Ohio
Steering Committee Chair
Has disclosed the following relevant financial relationships:
Research funding from: 89Bio; Abbott; Afimmune; Aker BioMarine; Amarin; Amgen; AstraZeneca; Bayer; Beren Therapeutics; Boehringer Ingelheim; Boston Scientific; Bristol Myers Squibb Company; Cardax; CellProthera; Cereno Scientific; Chiesi; CSL Behring; Eisai; Ethicon; Faraday Pharmaceuticals; Ferring; Forest Pharmaceuticals; Fractyl; Garmin; HLS Therapeutics; Idorsia; Ironwood Pharmaceuticals; Ischemix; Janssen; Javelin; Lexicon Pharmaceuticals; Lilly; Medtronic; Moderna; MyoKardia; NirvaMed; Novartis; Novo Nordisk; Owkin; Pfizer; PhaseBio; PLx; Recardio; Regeneron; Roche; Sanofi; Stasys Medical; Synaptic Pharmaceuticals; The Medicines Company
Steering Committee Member
Has disclosed the following relevant financial relationships:
Research funding from: Abbott; Agios Pharmaceuticals; Alexion; Alnylam; Amgen; Angionetics; Anthos Therapeutics; ARCA biopharma; Array BioPharma; AstraZeneca; Atentiv; Audentes Therapeutics; Bayer; Better Therapeutics; Bristol Myers Squibb Company; Cardiol Therapeutics; CellResearch; Cook Medical; Cook Regentec; CSL Behring; Eidos Therapeutics; Epizon Pharma; Esperion; EverlyWell; Faraday Pharmaceuticals; Fortress Biotech; HDL Therapeutics; HeartFlow; Hummingbird Bioscience; Insmed; Janssen; Kowa Research; Lexicon Pharmaceuticals; Medtronic; Merck; Moderna; Novate Medical; Novo Nordisk; Pfizer; PhaseBio; Prothena; Regeneron; Regio Biosciences; Sanifit; Sanofi; Silence Therapeutics; Stealth BioTherapeutics; VarmX; WraSer Pharmaceuticals
Owns stock (publicly traded) in: Medtronic; Pfizer
Steering Committee Member
Has disclosed the following relevant financial relationships:
Research funding from: Medtronic
Other: DSMB: Philips; Silk Road Medical
Steering Committee Member
Has disclosed the following relevant financial relationships:
Speaker or member of speakers bureau for: Abbott
Steering Committee Member
Has disclosed no relevant financial relationships.
Steering Committee Member
Has disclosed the following relevant financial relationships:
Consultant or advisor for: Boston Scientific; Inari Medical; Medtronic; Philips
Research funding from: Abbott; Inari